Photos are for representational functions solely. Picture courtesy: Particular Association
Within the month-to-month drug alert issued by the Central Drug Customary Management Group (CDSCO), the Central Drug Laboratory discovered that 74 samples manufactured by numerous corporations weren’t of normal high quality (NSQ), whereas the state drug testing laboratory recognized 93 samples that didn’t meet the prescribed high quality norms.
Following common regulatory monitoring actions, an inventory of (NSQ) and faux medicine is displayed on the CDSCO portal on a month-to-month foundation. This knowledge was launched in December 2025.
“This failure is particular to the batch of drugs examined by the federal government laboratory and issues about different medicines accessible available on the market should not warranted,” a memo launched by the ministry mentioned.
The report added that in December 2025, 4 drug samples from North Zone of Ghaziabad, one drug pattern from FDA Ahmedabad, one drug pattern from Bihar and one drug pattern from Maharashtra have been recognized as faux medicine manufactured by unauthorized producers utilizing model names owned by different corporations. This matter is underneath investigation and motion shall be taken in accordance with legal guidelines and laws.
This exercise to establish NSQ and counterfeit medicines is carried out recurrently in collaboration with state regulatory authorities to make sure these medicines are recognized and faraway from the market.
